JPRN-UMIN000026765招募中未知
Prospective, randomized, open-label, clinical trial comparing the effects of topiroxostat and febuxostat on serum uric acid, endothelial function and markers for kidney injury - Prospective, randomized, open-label, clinical trial comparing the effects of topiroxostat and febuxostat.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who has a history of allergy to topiroxostat or febuxostat. 2) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 3) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits. 4) Subjects who has already taken mercaptopurine hydrate, azathioprine, vidarabine, didanosine. 5) Subjects whose doctor in charge do not agree to join the trial 6) Subjects who has past medical histories of active hemorrhage, ulcer, stroke, optical hemorrhage, hemorrhagic tendency.
研究者
相似试验
已完成
4 期
Prospective, randomized, open-label, clinical trial comparing fibrate monotherapy and fibrate-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, and markers for anti-inflammatory properties/obesity/antioxidative propertiesdyslipidemiaJPRN-UMIN000002964ational Defense Medical College60
招募中
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of hydrogen tablet and placebo on blood pressure, endothelial function and makers for cardiovascular diseasesHypertensionJPRN-UMIN000021154Tokorozawa Heart Center34
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of statin monotherapy and statin-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, markers for anti-inflammatory properties/obesity/antioxidative propertiesCoronary artery diseasesJPRN-UMIN000002960ational Defense Medical College60
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of losartan (regular dose) /hydrochlorothiazide combination and losartan alone (high-dose) on blood pressure, endothelial function and markers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000002961ational Defense Medical College30
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of dapagliflozin and sitagliptin on glucose/lipids metabolism and endothelial function in diabetic patientsType 2 diabetesJPRN-UMIN000032705Tokorozawa Heart Center30